Joseph S. Cavanaugh

TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings

Ishani Pathmanathan, Sevim Ahmedov, Eric Pevzner et al. · The International Journal of Tuberculosis and Lung Disease · 2018 · 78 citations · Full text

Tuberculosis Prevention, Drug Resistance, Preventive Medicine +16

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis [Short communication]

Sarah E. Smith, Ekaterina V. Kurbatova, Joseph S. Cavanaugh et al. · The International Journal of Tuberculosis and Lung Disease · 2011 · 65 citations

World Health Organization, Pulmonary Tuberculosis, Health Sciences +15

Epidemiology of Pyrazinamide-Resistant Tuberculosis in the United States, 1999–2009

Ekaterina V. Kurbatova, Joseph S. Cavanaugh, Tracy Dalton et al. · Clinical Infectious Diseases · 2013 · 65 citations · Full text

Human Tuberculosis Caused by<i>Mycobacterium bovis</i>in the United States, 2006–2013

Colleen Scott, Joseph S. Cavanaugh, Robert Pratt et al. · Clinical Infectious Diseases · 2016 · 53 citations · Full text

Rifampicin-resistant &lt;I&gt;Mycobacterium tuberculosis&lt;/I&gt;: susceptibility to isoniazid and other anti-tuberculosis drugs [Short communication]

Ekaterina V. Kurbatova, Joseph S. Cavanaugh, N. Sarita Shah et al. · The International Journal of Tuberculosis and Lung Disease · 2012 · 43 citations · Full text

Tuberculosis Prevention, Pharmacotherapy, Antimicrobial Chemotherapy +21